Project Grant HT94252510554
Award Date
7/1/25
Completion Date
6/30/28
Dollars Obligated
$632K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Australia
Similar Awards
The University of Sydney was awarded a $3,580,840 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "HEROIC PROSTATE CANCER PRECISION HEALTH (PCAPH) AFRICA1K: POWERING PRECISION HEALTH TO IMPROVE PROSTATE CANCER OUTCOMES IN AFRICA", aims to conduct advanced biomedical research to transform healthcare for military service members and the broader public. The research will focus on...
The University of Sydney was awarded a $919,739 Project Grant from the Department of the Army Medical Command through its Military Medical Research and Development program (CFDA 12.420). The grant will fund a molecular epidemiological study from September 2021 through September 2025 examining the relationship between aspirin and NSAID use and ovarian cancer prognosis. The Military Medical Research and Development program aims to transform military and public health through innovative medical...
The University of Technology Sydney was awarded a $529,265 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research to identify novel circular RNA biomarkers detectable in blood plasma that can help facilitate the diagnosis of malignant pleural mesothelioma. The research will be performed from September 2022 through September 2025. The Military Medical Research and Development...
The University of Queensland in Australia was awarded a $1,488,596 Project Grant from the Department of the Army Medical Command to support melanoma research from September 2022 through September 2025. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research solutions for battlefield medicine and other health issues. Under this award, The University of Queensland...
The University of New South Wales (UNSW) was awarded a $2,059,003.85 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. Specifically, the funding will enable UNSW to conduct research aimed at understanding and overcoming resistance to new and emerging therapies in...
The University of Queensland in Australia was awarded a $744,744 USD project grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project titled "Understanding the Role of Immature Myeloid Cells in Early Melanoma Establishment" from September 30, 2022 to September 29, 2025. Through this funding, researchers at The University of Queensland will investigate the role of immature myeloid...
The Department of the Army Medical Command awarded $608,341 to Monash University under the Military Medical Research and Development federal grant program (CFDA 12.420) from September 15, 2022 through September 14, 2025. The project grant funding will support Monash University's research efforts to elucidate and suppress cells of origin of cutaneous melanoma. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
The University of Adelaide in Australia was awarded a $1,005,845 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from September 2022 through September 2025 to exploit prostate cancer metabolic dependencies to develop new therapeutics and circulating prognostic and predictive biomarkers. The Military Medical Research and Development program supports basic, applied, and...
The University of Queensland in Australia was awarded a $520,011 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from August 1, 2022 to July 31, 2025 on a novel mediator of cholangiocarcinoma that has potential as a diagnostic and treatment target. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
The University of Melbourne was awarded a $591,778 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research aimed at "Harnessing the Immune Response in Exceptionally Long-Term Survivors to Develop Novel Therapeutics." The project will run from May 1, 2024 to April 30, 2027. The University of Melbourne has a history of conducting federal research and consulting work in areas such as...